Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Passiflora, Crataegus, and Salix in mild to moderate anxiety
NCT00944268Phase 3Unknown
- Sponsor
- Ativus Farmacêutica
- Start
- Sep 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of passiflora incarnata, crataegus oxyacantha, white willow bark in anxiety disorder, sponsored by Ativus Farmacêutica. Status: unknown.
02
Drugs
passiflora incarnatacrataegus oxyacanthawhite willow bark
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT00944268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944268.